Triton Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2025-10-23.
Triton Therapeutics, Inc. filed a Form D notice of an exempt securities offering with the SEC on October 23, 2025. The filing reports $36.36M sold. Its industry group is Pharmaceuticals. It names Paul Fonteyne (Executive Officer, Director), Annie Mitsak (Director), Timothy Shannon (Director) (SEC Form D, October 23, 2025).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Triton Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-10-23 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Triton Therapeutics, Inc.
Free to see. No signup.
More on the people and the money behind Triton Therapeutics, Inc., from the filings we hold.
Pharmaceuticals raises filed within 90 days of this one, largest first.
Get an email when Triton Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Triton Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Triton Therapeutics, Inc. →Get the full cited report on Triton Therapeutics, Inc.
What the filing shows about Triton Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Triton Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Triton Therapeutics, Inc.'s address as 700 Fairfield Avenue, Suite 1, Stamford, CT 06902.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Triton Therapeutics, Inc. See pricing
Triton Therapeutics, Inc. is a registered filer with the SEC (CIK 2088152) and has filed since 2025-10-23. 1 filing is on record, the latest on 2025-10-23.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Triton Therapeutics, Inc.'s Form D of 2025-10-23 names Paul Fonteyne, Annie Mitsak, Timothy Shannon and 1 more as its officers, directors or promoters.
Its new offerings report $36.36M sold across 1 offering, as its own filings state.
Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week.
No amounts other than ordinary course employment compensation is being paid to officers and directors.
Checked away from the filing. What is below does not come from the record on sec.gov.
Triton Therapeutics is a clinical stage company developing first-in-class medicines targeted at autoimmune and fibrotic diseases.
The title and description the site itself served, answering 200, after redirecting from https://tritonthera.com. Not a cached copy and not the company's directory entry — what was live when we asked.
Paul Fonteyne is named as Executive Officer and Director on the Form D that Triton Therapeutics, Inc. filed with the SEC on 23 October 2025, one of 4 people that filing names.
Annie Mitsak is named as Director on the Form D that Triton Therapeutics, Inc. filed with the SEC on 23 October 2025, one of 4 people that filing names.
Timothy Shannon is named as Director on the Form D that Triton Therapeutics, Inc. filed with the SEC on 23 October 2025, one of 4 people that filing names.
Elena Grigoryeva is named as Director on the Form D that Triton Therapeutics, Inc. filed with the SEC on 23 October 2025, one of 4 people that filing names.
4 people named on the filing — 1 holding an executive role and 3 as directors only.
Named as of the 2025-10-23 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Triton Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Triton Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Triton Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Triton Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Triton Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-10-30 (tritonthera.com).
Each opens in a new tab, filled in for Triton Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/triton-therapeutics-inc-form-d-25000001